Mon. 11 Mar 2024, 4:41pm ET
Benzinga
News, Guidance
2024 Outlook
Teknova anticipates total revenue of $35 million to $38 million for the fiscal year ending December 31, 2024 ("2024"), which assumes roughly 10% growth in Lab Essentials and the remaining revenue from Clinical Solutions. The Company also anticipates free cash outflow of less than $18 million for 2024.